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Abstract A biological “circadian” clock governs nearly all aspects of mammalian
behavior and physiology. This control extends from activities of entire organ
systems down to individual cells, all of which contain autonomous molecular
clocks. Under this control, a significant fraction of the cellular metabolome—the
collection of all small-molecule metabolites—varies in abundance according to
time of day. Comparing the rhythmic expression of transcripts, proteins, and
metabolites has yielded valuable insights into clock-controlled physiological mech-
anisms. In the future, their analysis could provide a glimpse of instantaneous clock
phase, even providing notions of clock time based upon molecules within a single
breath. Such knowledge could be important for disease diagnosis and for
chronopharmacology.
Introduction: A Many-Clock Problem
A “master clock” tissue in mammals has been identified in the suprachiasmatic
nuclei (SCN) of the hypothalamus, about 20,000 neurons distributed into bilateral
nuclei just above the optic chiasma. Lesioning of this region results in loss of
circadian behavior and physiology under constant environmental conditions (East-
man et al. 1984), and transplantation results in circadian behavior corresponding to
that of the donor animal (Ralph et al. 1990). Although the SCN directs circadian
timing, the circuitry of which circadian clocks are composed is in fact much more
widespread: nearly every cell in the body contains an autonomous molecular
oscillator driven by feedback loops of transcription and translation of dedicated
“core clock” proteins (Brown and Azzi 2013). Therefore, circadian control of
complex physiology is at least in part a question of orchestration: on the one
hand, circadian signals from the SCN must synchronize peripheral oscillators
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elsewhere in the brain and body and, on the other, peripheral clocks must them-
selves direct circadian processes at a cellular level.
The ultimate consequences of this pervasive circadian control are that, in most
mammalian tissues, 6–20 % of all transcripts and proteins are expressed in circa-
dian fashion, i.e., with higher expression at one time of day and lower expression at
another (Panda et al. 2002; Storch et al. 2002; Reddy et al. 2006; Robles
et al. 2014). It is therefore not surprising that about 20 % of the mammalian
metabolome shows circadian variation in both mice and men (Minami
et al. 2009; Dallmann et al. 2012; Eckel-Mahan et al. 2012). Given the lower
complexity of the metabolome and its extremely high conservation across species
compared to the genome, an increasing number of studies have turned to
metabolomics analyses to understand circadian biology.
Normally, circadian clocks throughout the body remain in relative synchrony
with defined phase relationships. However, during timing shifts provoked by travel
and shiftwork, in pathological cases such as inflammation and disease, or even due
to the abnormal timing of food intake, this synchrony can be disrupted. For
example, if normally nocturnal rodents are fed only during the day, clock phase
in peripheral organs like liver and heart will change phase by nearly 12 h, while the
SCN remains unaltered (Damiola et al. 2000; Stokkan et al. 2001). On the other
hand, during a sudden change in light timing, the SCN will quickly alter its phase
whereas peripheral organs require multiple days to do so (Davidson et al. 2009).
Disease-mediated inflammation provides another example of peripheral clock
dampening or dephasing: in response to infection, the circadian amplitude of
transcription for multiple clock and clock-controlled genes decreases markedly
(Cavadini et al. 2007). Finally, in both brain and peripheral tissues, sleep-related
cellular signals can conflict with clock-related ones, leading to a dampening of
circadian amplitude of clock-controlled genes (Maret et al. 2007; Moller-Levet
et al. 2013; Archer et al. 2014). Both immediate and long-term consequences of
such “clock desynchrony” are only beginning to be understood. For example,
circadian amplitude in human subjects is directly correlated with survival time in
some cancers (Innominato et al. 2012), and multiple studies in both humans and
animals have linked shiftwork to increased disease and mortality (Viswanathan and
Schernhammer 2009; Evans and Davidson 2013). As we discuss further below,
metabolomics analyses could provide a powerful tool to study circadian phase and
amplitude in both humans and animal models, potentially linking these parameters
to human health in a wide variety of contexts.
An Overview of Circadian Metabolomics
Typically, comprehensive metabolomics analyses are conducted by flow injection
mass spectrometry. Thus, in a single assay lasting a few seconds, thousands of
peaks corresponding to individual metabolites can be detected. At the moment, a
significant limiting factor for these studies is the identification of the metabolites
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corresponding to each peak. Most commercially accessible platforms can discretely
identify a few hundred different substances, including lipids, amino acids, sugars,
enzymatic cofactors, and peptides and hormones. In at least one study, these
circadian metabolites have been compared to circadian transcripts in the same
tissues in rodents, allowing a direct and comprehensive look at cellular pathways
regulated in circadian fashion (Eckel-Mahan et al. 2012).
From this study, it was clear that the circadian clock exerts coordinated control
over a large number of metabolic pathways, including those controlling the abun-
dance of lipids, carbohydrates, and amino acids. Of course, given that food is itself
consumed in time-of-day-dependent fashion, it would be formally possible that
these variations could be indirect consequences of rhythmic activity, rather than
direct clock control. In mice, for example, without rhythmic feeding only a small
percentage of circadian transcripts continued to show diurnal oscillations (Vollmers
et al. 2009). In humans, however, a very different picture has emerged. By analyz-
ing metabolomics parameters from saliva and blood taken from humans kept in a
“constant routine” of immobile reclined posture, hourly isocaloric meals, and sleep
deprivation, Dallmann et al. (2012) could definitively rule out food-dependent
control: 17 % of metabolites in both matrices were rhythmic even in the absence
of rhythmic feeding, sleep, and activity (Fig. 1). These included lipids, carbohy-
drates, and amino acids, the same pathways that demonstrated metabolic control in
mice (Eckel-Mahan et al. 2012). The same study also showed that the abundance of
some metabolites increased or decreased monotonically with sleep deprivation,
implying that sleep pressure and circadian influences might independently regulate
diurnal metabolic physiology.
Metabolomics: Applications for Circadian Medicine
Because various circadian metabolites show peak abundance at different times of
day, it is possible to use these relative quantities as indicators of timing. The idea is
analogous to the “chronological garden” of the Swedish botanist Carl Linnaeus,
who used plants flowering at different times of day to determine geological time at
any moment. In precisely the same fashion, Minami et al. (2009) used blood
metabolites from mice as a way of detecting circadian body time, and Martinez-
Lozano Sinues et al. (2014) used metabolites within human breath. While poten-
tially quite powerful, these molecular timetable-based methods are hampered by the
high inter-individual variability of metabolite abundance among different subjects,
making single-time-point analyses relatively imprecise. So far, an accuracy of
about 2 h in circadian time is the best that has been attained. As more individuals
are metabolomically characterized into different endophenotypic subtypes, it is
likely that this accuracy will increase substantially.
Major applications of such technology would be twofold. First and most simply,
it would be possible to determine human body time prior to clinical intervention.
For most drugs, both pharmacokinetics and pharmacodynamics vary in circadian
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fashion. In other words, not only is the metabolism of many xenobiotic substances
strongly regulated but also the biological targets of the drugs themselves (Dallmann
et al. 2014). Thus, potentially both increased efficacy and reduced toxicity could be
obtained by precise timing of delivery, at least in the case of unstable compounds.
Currently, multiple clinical trials have been run or are running, especially in the
field of cancer, to test this concept (Innominato et al. 2014). Since cell division has
been shown to be coordinated with circadian clock timing in both adult animals and
cells (Matsuo et al. 2003; Nagoshi et al. 2004; Kowalska et al. 2013; Bieler
























Fig. 1 (a) Heat map of circadian metabolites identified in human blood (left) and saliva (right)
from subjects maintained in a constant routine of hourly isocaloric meals, immobile posture,
constant dim light, and sleep deprivation. Rows: individual metabolites; columns: time relative to
start of experiment. (b) Major classes of compounds identified in blood (top) and saliva (bottom),
plotted in circadian time relative to theoretical dawn (Adapted from Dallmann et al. 2012)
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by circadian isoforms of cytochrome P450 in the liver, it is logical to imagine that
chemotherapeutic toxicity would itself be circadian. This concept has been dem-
onstrated experimentally in mice (Gorbacheva et al. 2005), and human trials have
also shown time-of-day-dependent effects (Innominato et al. 2014).
Secondly, metabolite timetable-based methods would be able to predict not only
clock phase but also clock amplitude and possibly even circadian desynchrony.
These parameters have been increasingly linked to disease both in humans and in
animal models, as mentioned in the introduction, leading the World Health Orga-
nization to classify shiftwork as a suspected carcinogen. Even a simple indicator
like the amplitude of circadian behavior correlates directly with survival during
chemotherapy of metastatic colon carcinoma in humans (Innominato et al. 2012).
It is suspected that one of the main deleterious effects of shiftwork is circadian
desynchrony among different organs. In mice, changes in daylight timing shift
different organs at different speeds (Davidson et al. 2009). Potentially,
metabolomics could give insight into this phenomenon, since various circadian
components come from different tissues. For example, the hormone melatonin is
secreted by the pineal gland of the hypothalamus and is thought to be a direct output
of the SCN. By contrast, many other endocrine factors and metabolites detectable in
blood or in breath arise primarily as byproducts of peripheral organ function
(Gamble et al. 2014). Therefore, we propose that circadian metabolomics could
be useful in elucidating desynchrony between clocks in brain and in other periph-
eral tissues. To date, no studies have used metabolomics methods in this fashion,
but great potential exists.
Outlook and Conclusion
Questions of circadian desynchrony in health and disease are only beginning to be
addressed. The idea that shiftwork might affect circadian clock function is easy to
see. However, many other factors could play important and unsuspected roles. For
example, recent studies have suggested that chronic sleep restriction alone, even
without changed diurnal patterns of activity, could also disrupt circadian transcrip-
tion (Moller-Levet et al. 2013). Similarly, depressive and affective disorders have
long been known to be accompanied by dramatically different sleep–wake patterns
(Lamont et al. 2007). Recent research has established a close tie between circadian
dysfunction and metabolic disorders like obesity and diabetes (Maury et al. 2014).
All of these syndromes are potentially explorable by circadian metabolomics. The
conclusions that such studies might derive could both answer outstanding questions
about circadian biology and improve human health.
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